Table 2.

Proportion of patients with and without relapse and 90/95% Wilson confidence intervals (FAS, CC cohort) within 4 months after D1

	Patients N (%)	Binominal proportion	95% Wilson confidence interval
			Lower limit	Upper limit
Without relapse within 4 months after D1 (primary endpoint)
FAS (Nvalid = 63)
Yes	40 (63.5)	0.635	0.5115	0.7428
No	23 (36.5)
CC cohort (N = 54, 100%)
Yes	39 (72.2)	0.722	0.5911	0.8238
No	15 (27.8)
Without relapse within 3 months after D1 (secondary endpoint)
FAS (Nvalid = 68)
Yes	47 (69.1)	0.691	0.5736	0.7883
No	21 (30.9)
CC cohort (N = 54, 100%)
Yes	41 (75.9)	0.759	0.6305	0.8536
No	13 (24.1)
Without relapse within 2 months after D1 (secondary endpoint)
FAS (Nvalid = 69)
Yes	53 (76.8)	0.768	0.6560	0.8519
No	16 (23.2)
CC cohort (N = 54, 100%)
Yes	45 (83.3)	0.833	0.7126	0.9098
No	9 (16.7)
Without relapse within 1 month after D1 (secondary endpoint)
FAS (N = 70, 100%)
Yes	60 (85.7)	0.857	0.7566	0.9205
No	10 (14.3)
CC cohort (N = 54, 100%)
Yes	49 (90.7)	0.907	0.8009	0.9598
No	5 (9.3)